Chargement en cours...
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
The deregulation of lipid metabolism is a hallmark of tumor cells, and elevated lipogenesis has been reported in prostate cancer. Metformin, a drug commonly prescribed for type II diabetes, displays antitumor properties. Here, we show that metformin inhibits lipogenesis in several prostate cancer ce...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4558177/ https://ncbi.nlm.nih.gov/pubmed/26002551 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|